Ms2.87-97

Ms2.87-97 has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, Apr 8, 2026: “A VLP-based immunogen that elicits selective anti-Myostatin antibodies, enhances muscle mass and strength, and reduces adiposity”.

Intervention

1 paper studies it4 findingsUpdated

See all 1 papers on ms2.87-97

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Animals1

What did studies of ms2.87-97 find?

4

Studies of ms2.87-97 measured 4 outcomes, among them fibrosis, muscle mass and grip strength.

Fibrosis

no changein mice1

1 study
  1. Ms2.87-97 showed no clear effect on fibrosis in mice.

    “histological analysis showed no change in myocardial collagen deposition (fibrosis).”

    AnimalsVLP-based active immunotherapymyocardium

    A VLP-based immunogen that elicits selective anti-Myostatin antibodies, enhances muscle mass and strength, and reduces adiposity

    bioRxiv : the preprint server for biologyPreprint

More on Fibrosis

Muscle mass

upin mice1

1 study
  1. Ms2.87-97 increases muscle mass in mice.

    “upon dissection, they were found to have increased muscle mass.”

    AnimalsVLP-based active immunotherapyskeletal muscle

    A VLP-based immunogen that elicits selective anti-Myostatin antibodies, enhances muscle mass and strength, and reduces adiposity

    bioRxiv : the preprint server for biologyPreprint

More on Muscle mass

Grip strength

upin mice1

1 study
  1. Ms2.87-97 improves grip strength in mice.

    “MS2.87-97-treated mice also had significantly improved bodyweight-adjusted grip strength”

    AnimalsVLP-based active immunotherapy

    A VLP-based immunogen that elicits selective anti-Myostatin antibodies, enhances muscle mass and strength, and reduces adiposity

    bioRxiv : the preprint server for biologyPreprint

More on Grip strength

Body fat percentage

downin mice1

1 study
  1. Ms2.87-97 decreases body fat percentage in mice.

    “Compared to controls, MS2.87-97-treated mice had less age-associated weight gain and exhibited significantly reduced body fat by DEXA scan.”

    AnimalsVLP-based active immunotherapyadipose tissue

    A VLP-based immunogen that elicits selective anti-Myostatin antibodies, enhances muscle mass and strength, and reduces adiposity

    bioRxiv : the preprint server for biologyPreprint

More on Body fat percentage

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 1May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months